Merck & Co. , Inc. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Merck & Co. with three other
companies in this sector in the United States:
sales of $38.31 billion
of which 84%
of which 66%
was innovative medicines), and
of which 58%
Merck & Co. reported sales of $39.81 billion
December of 2016.
a very small
increase of 0.8%
versus 2015, when the company's sales were $39.50 billion.
Despite this increase, sales are still
below the level achieved in 2014, when Merck & Co.
reported sales of $42.24 billion.
Sales of All Other saw an increase
that was more than double the company's growth rate: sales were up
5.5% in 2016, from
$3.66 billion to $3.86 billion.
Merck & Co. also saw significant increases in sales in
Merck Pharmaceutical (up 1.1% to $35.15 billion)
Not all segments of Merck & Co. experienced an increase in sales in 2016:
sales of Unallocated fell 24.9% to $794.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).